Saving Sight Medical Director Shares Insights on Use of Serum Tears in Ocular Surface Disease

Joseph Tauber, MD, presented on the use of serum tears in March

On Wednesday, March 3, ophthalmologist and Saving Sight Medical Director, Joseph Tauber, MD, presented on using serum tears therapy in ocular surface disease. The webinar was hosted by Vital Tears, an organization that offers autologous serum tears to eye care professionals and their patients throughout the nation. Saving Sight is a co-founder of Vital Tears, and processes all orders for the serum tears in its laboratory.

Dr. Tauber has an in-depth understanding of the use of serum tears in patients with ocular surface disease, as he was an early adopter of using Vital Tears in his practice. During the webinar Dr. Tauber shared insights into how serum tears fit into a treatment plan for dry eye disease, as well how Vital Tears has simplified the process for patients and physicians.

In addition to serving as Saving Sight’s medical director, Dr. Tauber is a recognized authority in the field of ocular surface diseases, including dry eye. Avidly involved in research for almost three decades, Dr. Tauber has been a principal investigator in over 125 research studies of high-risk corneal transplantation, inflammation and allergic eye diseases, corneal infectious diseases and numerous studies related to dry eye syndrome.

If you’re interested in learning more about the innovative approach that Vital Tears is taking in partnership with Saving Sight to restore sight, visit www.vitaltears.org.